Selected Grants
Interval Colonoscopy Screening for the Detection of Dysplasia in Inflammatory Bowel Disease
ResearchMentor · Awarded by American College of Gastroenterology · 2023 - 2025An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis ELEVATE UC OLE: An Open-Label Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Clinical TrialPrincipal Investigator · Awarded by Arena Pharmaceuticals, Inc. · 2020 - 2024A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction Therapy in Subjects with Moderately to Severely Active Crohn's Disease
Clinical TrialPrincipal Investigator · Awarded by Arena Pharmaceuticals, Inc. · 2020 - 2024A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis
Clinical TrialPrincipal Investigator · Awarded by Arena Pharmaceuticals, Inc. · 2021 - 2023A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn's Disease
Clinical TrialPrincipal Investigator · Awarded by Janssen Research & Development, LLC · 2018 - 2022DG29 SERES
Clinical TrialPrincipal Investigator · Awarded by Seres Therapeutics, Inc · 2019 - 2021Boehringer Ingelheim Pharmaceuticals Inc - Industry - BI 655130 in Ulcerative Colitis Subjects
Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Corporation · 2019 - 2020GS-US-326-1100 Dr. Onken Study
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2015 - 2017The Role of NAG-1 in Inflammatory Bowel Disease
Clinical TrialPrincipal Investigator · Awarded by National Institute of Environmental Health Sciences · 2008 - 2010Bromelain-Based Biological Therapy for IBD
ResearchPhysician · Awarded by National Institutes of Health · 2004 - 2007External Relationships
- American Board of Internal Medicine
- Arena Pharmaceuticals
- Janssen Pharmaceuticals (Johnson & Johnson)
- Merck & Co. USA (not assoc'd with Merck KGaA)
- Pfizer Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.